149 related articles for article (PubMed ID: 30680665)
1. Optimal dosage of methotrexate for GVHD prophylaxis in umbilical cord blood transplantation.
Adachi Y; Ozeki K; Ukai S; Sagou K; Fukushima N; Kohno A
Int J Hematol; 2019 Apr; 109(4):440-450. PubMed ID: 30680665
[TBL] [Abstract][Full Text] [Related]
2. Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil.
Terakura S; Wake A; Inamoto Y; Murata M; Sakai R; Yamaguchi T; Takahashi S; Uchida N; Onishi Y; Ohashi K; Ozawa Y; Kanamori H; Yamaguchi H; Fukuda T; Ichinohe T; Takanashi M; Atsuta Y; Teshima T
Bone Marrow Transplant; 2017 Mar; 52(3):423-430. PubMed ID: 27941766
[TBL] [Abstract][Full Text] [Related]
3. Comparative Study of Tacrolimus and Short-Term Methotrexate: 2-Day versus 3-Day Methotrexate as Graft-versus-Host-Disease Prophylaxis after Umbilical Cord Blood Transplantation in Adults.
Hattori N; Saito B; Matsui T; Nakata A; Sasaki Y; Shimada S; Murai S; Abe M; Baba Y; Watanuki M; Fujiwara S; Kawaguchi Y; Arai N; Kabasawa N; Tsukamoto H; Uto Y; Yanagisawa K; Harada H; Nakamaki T
Biol Blood Marrow Transplant; 2020 Feb; 26(2):367-372. PubMed ID: 31678538
[TBL] [Abstract][Full Text] [Related]
4. Effect of methotrexate dose in graft-versus-host disease prophylaxis after single-unit cord blood transplantation in adult acute myeloid leukemia.
Terakura S; Kuwatsuka Y; Sugita J; Takahashi S; Ozawa Y; Ozeki K; Yoshioka S; Nakamae H; Kawakita T; Sawa M; Morishige S; Najima Y; Katsuoka Y; Sakaida E; Kouzai Y; Kimura T; Ichinohe T; Fukuda T; Atsuta Y; Murata M; Teshima T
Int J Hematol; 2021 Jun; 113(6):840-850. PubMed ID: 33611725
[TBL] [Abstract][Full Text] [Related]
5. Comparison of calcineurin inhibitors in combination with conventional methotrexate, reduced methotrexate, or mycophenolate mofetil for prophylaxis of graft-versus-host disease after umbilical cord blood transplantation.
Yoshida S; Ohno Y; Nagafuji K; Yoshimoto G; Sugio T; Kamimura T; Ohta T; Takase K; Henzan H; Muta T; Iwasaki H; Ogawa R; Eto T; Akashi K; Miyamoto T
Ann Hematol; 2019 Nov; 98(11):2579-2591. PubMed ID: 31628517
[TBL] [Abstract][Full Text] [Related]
6. Reduced dose of MTX for GVHD prophylaxis promotes engraftment and decreases non-relapse mortality in umbilical cord blood transplantation.
Shiratori S; Ohigashi H; Takahashi S; Ara T; Goto H; Nakagawa M; Sugita J; Onozawa M; Kahata K; Endo T; Hashimoto D; Teshima T;
Ann Hematol; 2020 Mar; 99(3):591-598. PubMed ID: 32006152
[TBL] [Abstract][Full Text] [Related]
7. Minimum-Dose, Short-Term Methotrexate With Tacrolimus for Graft-vs-Host Disease Prophylaxis Following Unrelated Cord Blood Transplantation in Adults: A Retrospective Analysis at a Single Institution.
Iino M; Sato T; Sakamoto Y
Transplant Proc; 2021; 53(1):396-404. PubMed ID: 33308840
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of graft-versus-host disease prophylaxis with tacrolimus in combination with methylprednisolone or methotrexate after umbilical cord blood transplantation.
Shigemura T; Sakashita K; Okura E; Morita D; Komori K; Kurata T; Hirabayashi K; Saito S; Tanaka M; Yanagisawa R; Nakazawa Y
Int J Hematol; 2020 May; 111(5):702-710. PubMed ID: 31953722
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of the dosage of methotrexate combined with tacrolimus for graft-versus-host disease prophylaxis after cord blood transplantation.
Adachi M; Yokota D; Hirata H; Koyauchi K; Dohtan S; Oka S; Sakamoto N; Takaba M; Takemura T; Nagata Y; Naito K; Ono T
Int J Hematol; 2021 Aug; 114(2):252-262. PubMed ID: 34086252
[TBL] [Abstract][Full Text] [Related]
10. Umbilical cord blood transplantation for adults using tacrolimus with two-day very-short-term methotrexate for graft-versus-host disease prophylaxis.
Saito B; Hattori N; Yamamoto K; Arai N; Kawaguchi Y; Fujiwara S; Kabasawa N; Tsukamoto H; Uto Y; Ariizumi H; Yanagisawa K; Nakamaki T
Leuk Res; 2016 Aug; 47():161-5. PubMed ID: 27376545
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-host disease (GVHD) prophylaxis by using methotrexate decreases pre-engraftment syndrome and severe acute GVHD, and accelerates engraftment after cord blood transplantation.
Iguchi A; Terashita Y; Sugiyama M; Ohshima J; Sato TZ; Cho Y; Kobayashi R; Ariga T
Pediatr Transplant; 2016 Feb; 20(1):114-9. PubMed ID: 26526424
[TBL] [Abstract][Full Text] [Related]
12. A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey.
Sakai R; Taguri M; Oshima K; Mori T; Ago H; Adachi S; Morita S; Taniguchi S; Fukuda T; Ohashi K; Eto T; Miyamura K; Iwato K; Kobayashi N; Kanamori H; Morishima Y; Nagamura-Inoue T; Sakamaki H; Atsuta Y; Murata M
Int J Hematol; 2016 Mar; 103(3):322-33. PubMed ID: 26800676
[TBL] [Abstract][Full Text] [Related]
13. Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults.
Narimatsu H; Terakura S; Matsuo K; Oba T; Uchida T; Iida H; Hamaguchi M; Watanabe M; Kohno A; Murata M; Sawa M; Miyamura K; Morishita Y
Bone Marrow Transplant; 2007 Jan; 39(1):31-9. PubMed ID: 17115066
[TBL] [Abstract][Full Text] [Related]
14. Reduced-dose methotrexate in combination with tacrolimus was associated with rapid engraftment and recovery from oral mucositis without affecting the incidence of GVHD.
Matsukawa T; Hashimoto D; Sugita J; Nakazawa S; Matsushita T; Kashiwazaki H; Goto H; Onozawa M; Kahata K; Fujimoto K; Endo T; Kondo T; Hashino S; Yamazaki Y; Teshima T
Int J Hematol; 2016 Jul; 104(1):117-24. PubMed ID: 27119977
[TBL] [Abstract][Full Text] [Related]
15. GVHD prophylaxis by tacrolimus and mini-MTX in single-unit CBT: a single institute experience.
Fuji S; Tada Y; Nakata R; Nakata K; Koike M; Kida S; Tsutsumi K; Masaie H; Yoshida H; Ishikawa J
Int J Hematol; 2020 Feb; 111(2):278-283. PubMed ID: 31659626
[TBL] [Abstract][Full Text] [Related]
16. Cord blood transplantation from unrelated donors for children with acute lymphoblastic leukemia in Japan: the impact of methotrexate on clinical outcomes.
Kato K; Yoshimi A; Ito E; Oki K; Hara J; Nagatoshi Y; Kikuchi A; Kobayashi R; Nagamura-Inoue T; Kai S; Azuma H; Takanashi M; Isoyama K; Kato S;
Biol Blood Marrow Transplant; 2011 Dec; 17(12):1814-21. PubMed ID: 21664471
[TBL] [Abstract][Full Text] [Related]
17. GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia.
Terakura S; Kuwatsuka Y; Yamasaki S; Wake A; Kanda J; Inamoto Y; Mizuta S; Yamaguchi T; Uchida N; Kouzai Y; Aotsuka N; Ogawa H; Kanamori H; Nishiwaki K; Miyakoshi S; Onizuka M; Amano I; Fukuda T; Ichinohe T; Atsuta Y; Murata M; Teshima T
Bone Marrow Transplant; 2017 Sep; 52(9):1261-1267. PubMed ID: 28604665
[TBL] [Abstract][Full Text] [Related]
18. Substitution of methotrexate with corticosteroid for acute graft-versus-host disease prevention in transplanted patients who develop methotrexate toxicity.
Kim SY; Kim AR; Yoon SY; Cho YH; Lee MH
Ann Hematol; 2016 Feb; 95(3):483-91. PubMed ID: 26658911
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT.
Cutler C; Logan B; Nakamura R; Johnston L; Choi S; Porter D; Hogan WJ; Pasquini M; MacMillan ML; Hsu JW; Waller EK; Grupp S; McCarthy P; Wu J; Hu ZH; Carter SL; Horowitz MM; Antin JH
Blood; 2014 Aug; 124(8):1372-7. PubMed ID: 24982504
[TBL] [Abstract][Full Text] [Related]
20. Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD prevention.
Khimani F; Kim J; Chen L; Dean E; Rizk V; Betts B; Nishihori T; Locke F; Mishra A; Perez L; Ayala E; Kharfan-Dabaja M; Nieder M; Fernandez H; Anasetti C; Pidala J
Bone Marrow Transplant; 2017 Jul; 52(7):1003-1009. PubMed ID: 28368376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
